This variability highlights the challenges of using PBMC-derived biomarkers in the context of PDAC and suggest that, although INS mRNA expression may reflect systemic metabolic changes associated with the disease, it cannot be entirely linked to tumor-specific gene expression in this study. Here, INS is linked to neoplasm.